HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People On The Move: Appointments At Orkla, PAGB, Afepadi

Executive Summary

A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.

You may also be interested in...



EU Business News: Orkla Acquires Healthspan, Bayer Invests Locally, Ipsen Targets Baltics

A round-up of the latest European consumer health business news: Norway's Orkla strengthens its supplements offering with acquisition of UK's Healthspan; Bayer makes investment commitment to German Consumer Health operation; and Ipsen strikes a deal to promote brands in the Baltics.

EU Set To Maintain Safe Intake Levels For Vitamin D And Folate In Supplements

Positive news for dietary supplement manufacturers as EFSA plans to maintain the existing tolerable upper intake levels for vitamin D and folate. The regulator recently revealed plans to cut levels for vitamin B6 and selenium.

People On The Move: Appointments At Reckitt, Nestlé, H&H

A round-up of the latest appointments in the health and wellness industries: Reckitt names new Health and Nutrition presidents; Nestle hires external CFO; and H&H announces new CEO.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel